English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    X

    eye-on-india

    Big Story | Serum Institute seeks emergency clearance in India for COVID-19 vaccine. What happens next?

    Serum Institute is now seeking the DCGI nod For emergency use authorisation of its vaccine candidate Covishield In India. More here.

    first published: Dec 7, 2020 06:50 pm

    LATEST VIDEOS

    Watch More →

    A collection of the most-viewed Moneycontrol videos.

    Watch and Follow our leading shows

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347